Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient-provider communication

The objective of this study was to systematically characterize the content and patterning of companion’s communicative behavior during oncology consultations for older African-American male patients. Companions and family members often play an important role in patient-centered communication for patients with cancer. Despite their disproportionate cancer burden, little is known about how companions facilitate patient-provider communication for older African-American men with cancer. This study represents a secondary qualitative analysis of 14 video-recorded doctor patient-companion medical visits for African-American male patients with cancer. Videos were captured with consent and institutional review board approval at a Midwest comprehensive cancer center between 2002 and 2006. These medical visits were transcribed, deidentified, and analyzed for the content, frequency, co-occurrence, and thematic clustering of companions’ active participation behaviors during the interaction. Results were well aligned with existing studies on accompanied oncology visits. Patients were on average, 60.14 years old and all but one of the 16 companions was a woman. A total 782 companion behaviors were coded across 14 medical interactions. While companions communicated directly with providers (eg, asking questions, providing medical history) and directly with patients (eg, clarifying information, giving advice), there was a lack of triadic communication. This study clarifies the role of mainly spousal companions as important intermediaries in the patient-provider communication dynamic for older African-American men with cancer.

Download Full-text

JUUL electronic cigarette use patterns, other tobacco product use, and reasons for use among ever users: Results from a convenience sample

Addictive Behaviors ◽

10.1016/j.addbeh.2019.02.011 ◽

2019 ◽

Vol 95 ◽

pp. 178-183 ◽

Cited By ~ 19

Author(s):

Eleanor L.S. Leavens ◽

Elise M. Stevens ◽

Emma I. Brett ◽

Emily T. Hébert ◽

Andrea C. Villanti ◽

...

Keyword(s):

Tobacco Product ◽

Electronic Cigarette ◽

Cigarette Use ◽

Convenience Sample ◽

Use Patterns ◽

Product Use ◽

Reasons For Use

Download Full-text

Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes

Cancer ◽

10.1002/cncr.28811 ◽

2014 ◽

Vol 120 (22) ◽

pp. 3527-3535 ◽

Cited By ~ 104

Author(s):

Sarah P. Borderud ◽

Yuelin Li ◽

Jack E. Burkhalter ◽

Christine E. Sheffer ◽

Jamie S. Ostroff

Keyword(s):

Smoking Cessation ◽

Electronic Cigarette ◽

Cigarette Use ◽

Patients With Cancer

Download Full-text

Nicotine and Cotinine Levels With Electronic Cigarette

International Journal of Toxicology ◽

10.1177/1091581815618935 ◽

2015 ◽

Vol 35 (2) ◽

pp. 179-185 ◽

Cited By ~ 44

Author(s):

A. Marsot ◽

N. Simon

Keyword(s):

Peak Concentration ◽

Electronic Cigarettes ◽

Electronic Cigarette ◽

Cigarette Use ◽

Quit Smoking ◽

Tobacco Cigarette ◽

Nicotine Delivery ◽

Pubmed Database ◽

Urge To Smoke ◽

Reasons For Use

Background: Since their introduction in 2004, electronic cigarettes (e-cigarettes) have gained popularity worldwide. E-cigarettes are marketed as nicotine delivery devices. Commonly reported reasons for use include to quit smoking, to reduce urge to smoke, or the perceived lower risk alternative to smoking. But what are the actual amounts of nicotine delivered? Aim: This review summarizes all the published studies concerning nicotine or cotinine levels following e-cigarette use. Methods: A literature search was conducted from the PubMed database, from 1985 to January 2014, using the following terms: electronic cigarette(s), e-cigarette(s), electronic nicotine delivery system, cotinine, and nicotine. Articles were excluded if they were not pertinent according to our criteria. References of all relevant articles were also evaluated. Results: Eight studies were included in this review. The following information was extracted from the articles: population size, age of participants, recruitment, inclusion and exclusion criteria, concentration of nicotine in refills liquids, study sample design, and observed concentrations. Following design of studies, plasma nicotine Cmax was observed between 0 and 5 ng/mL (no significant changes) or between 13.9 and 16.3 ng/mL (similar to a tobacco cigarette) with a Tmax between 70 and 75 minutes. Cotinine levels after “vaping” an e-cigarette are similar to a tobacco cigarette. Conclusion: This review summarizes e-cigarette studies that contain information on nicotine or cotinine levels. The peak concentration of nicotine appears to be dependent on the use and dose level of e-cigarette cartridge. The value of this peak concentration is similar to the value found with a tobacco cigarette. However, the time corresponding to the peak concentration is delayed compared to a tobacco cigarette.

Download Full-text

Electronic cigarette use among university students aged 18–24 years in New Zealand: results of a 2018 national cross-sectional survey

BMJ Open ◽

10.1136/bmjopen-2019-035093 ◽

2020 ◽

Vol 10 (6) ◽

pp. e035093 ◽

Cited By ~ 1

Author(s):

Ben Wamamili ◽

Mark Wallace-Bell ◽

Ann Richardson ◽

Randolph C Grace ◽

Pat Coope

Keyword(s):

New Zealand ◽

University Students ◽

Cross Sectional Study ◽

Electronic Cigarette ◽

Cigarette Use ◽

Cross Sectional Survey ◽

Cross Sectional ◽

High Prevalence ◽

Free Spaces ◽

Reasons For Use

ObjectivesTo examine electronic cigarette use, reasons for use and perceptions of harm among university students.DesignCross-sectional study.SettingUniversity students across New Zealand.MethodsWe analysed data from a 2018 cross-sectional survey of university students, weighted to account for undersampling and oversampling by gender and university size. χ2 tests were used to compare e-cigarette use, reasons for use and perceptions of harm by age, gender, ethnicity and cigarette smoking.ParticipantsThe sample comprised 1476 students: 62.3% aged 18–20 years, 37.7% aged 21–24 years; 38.6% male, 61.4% female; 7.9% Māori and 92.1% non-Māori.Results40.5% of respondents (95% CI 37.9 to 43.1) reported ever, 6.1% (4.9–7.4) current and 1.7% (1.1–2.5) daily use. Regardless of frequency, 11.5% of vapers had vaped daily for ≥1 month, 70.2% of whom used nicotine-containing devices; 80.8% reported not vaping in indoor and 73.8% in outdoor smoke-free spaces. Among ever vapers, curiosity (67.4%), enjoyment (14.4%) and quitting (2.4%) were common reasons for vaping. 76.1% (73.4–78.7) of respondents believed e-cigarettes were less harmful than cigarettes.More males than females reported vaping (ever, current, daily and daily for ≥1 month), nicotine use and belief that e-cigarettes were less harmful than cigarettes. More participants aged 18–20 years reported not vaping in outdoor smoke-free spaces, vaping out of curiosity and belief that e-cigarettes were less harmful than cigarettes, while more participants aged 21–24 years vaped daily for ≥1 month and for enjoyment. More Māori than non-Māori ever vaped. More cigarette smokers than non-smokers vaped (ever, current, daily and daily for ≥1 month), used nicotine and vaped to quit, while more non-smokers did not vape in smoke-free spaces and vaped out of curiosity.ConclusionsOur results suggest high prevalence of e-cigarette ever and current use, particularly among males and smokers. Many vaped out of curiosity and perceived e-cigarettes as less harmful than cigarettes.

Download Full-text